Medicure Inc 6-K, filed Oct 21, 2020
Medicure Inc (MCUJF)
About this 6-K
Medicure Inc filed this 6-K on October 21, 2020.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2020
Commission File Number: 001-31995
MEDICURE INC.
(Translation of registrant's name into English)
2-1250 Waverley Street
Winnipeg, MB Canada R3T 6C6
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 8a72____.
EXHIBIT LIST
| Exhibit | Title |
| 99.1 | Notice of Change in Auditor dated October 16, 2020 |
| 99.2 | Letter from the Former Auditor dated October 19, 2020 |
| 99.3 | Letter from the Successor Auditor dated October 16, 2020 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Medicure Inc. | ||
| (Registrant) | ||
| Date: October 20, 2020 | By: | /s/ Dr. Albert D. Friesen |
| Dr. Albert D. Friesen | ||
| Title: CEO | ||
Exhibit 99.1
 |
2-1250 Waverley Street Winnipeg, Manitoba, Canada R3T 6C6 Phone: 204-487-7412 Fax: 204-488-9823 |
October 16, 2020
British Columbia Securities Commission
Alberta Securities Commission
Saskatchewan Securities Commission
Manitoba Securities Commission
Ontario Securities Commission
Autorite des marches financiers
New Brunswick Securities Commission
Nova Scotia Securities Commission
Prince Edward Island Securities Commission
Securities Commission of Newfoundland and Labrador
| Ernst & Young LLP | PwC Canada |
| 2700 – 360 Main Street | 1 Lombard Place, Suite 2300 |
| Winnipeg, MB R3C 4G9 | Winnipeg, MB R3B 0X6 |
RE: Notice of Change in Auditor
This notice is made pursuant to National Instrument 51-102 (“NI 51-102”).
PwC Canada (“PwC”) were appointed the auditors of Medicure Inc., (the “Corporation”) on November 21, 2018. The Corporations’ shareholders approved at the last annual meeting of the shareholders of the Corporation held June 22, 2020 that PwC be reappointed auditors of the Corporation until the next annual meeting.
The Board of Directors, upon the recommendation of the Audit Committee, has decided not to renew PwC’s appointment as auditor. The audit committee has reviewed the situation and determined that the appointment of Ernst & Young LLP (“EY”) as auditors of the Corporation would be in the best interests of the Corporation. As such, the Company’s audit committee has recommended that EY be appointed as the successor auditor and the Board of Directors have approved the same on October 6, 2020.
There have been no reservations in the auditor’s reports for the audits of the three most recently completed fiscal years.
There have been, in the opinion of the Corporation, no reportable events, as that term is defined in NI 51-102.
The board of directors of the Corporation has reviewed and approved the reporting package as that term is defined in NI 51-102.
Sincerely,
MEDICURE INC.
Per:
/s/ James Kinley
_______________________
James Kinley CPA, CA
Chief Financial Officer
Exhibit 99.2
Exhibit 99.3
October 16, 2020
Alberta Securities Commission
British Columbia Securities Commission
Manitoba Securities Commission
Ontario Securities Commission
Saskatchewan Securities Commission
Autorite des marches financiers
New Brunswick Securities Commission
Nova Scotia Securities Commission
Prince Edward Island Securities Commission
Securities Commission of Newfoundland and Labrador
Dear Sirs/Mesdames:
Re: Medicure Inc.
Change of Auditor Notice dated 2020/10/16
Pursuant to National Instrument 51-102 (Part 4.11), we have read the above-noted Change of Auditor Notice and confirm our agreement with the information contained in the Notice pertaining to our firm.
Yours sincerely,
cc: The Board of Directors, Medicure Inc.